A detailed history of Israel Englander (Millennium Management LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Millennium Management LLC holds 4,718,600 shares of PFE stock, worth $130 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,718,600
Previous 4,379,700 7.74%
Holding current value
$130 Million
Previous $122 Million 8.63%
% of portfolio
0.06%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $307 Million - $360 Million
12,145,685 Added 156.19%
19,921,844 $557 Million
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $45.5 Million - $52.3 Million
-1,759,324 Reduced 18.45%
7,776,159 $216 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $207 Million - $269 Million
7,921,687 Added 490.87%
9,535,483 $275 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $23.1 Million - $26.7 Million
639,938 Added 65.71%
1,613,796 $59.2 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $5.94 Million - $7.73 Million
-150,750 Reduced 13.4%
973,858 $39.7 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $24.5 Million - $32 Million
-587,233 Reduced 34.3%
1,124,608 $57.6 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $69.5 Million - $84.8 Million
1,587,540 Added 1277.17%
1,711,841 $74.9 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $157 Million - $186 Million
-3,366,305 Reduced 96.44%
124,301 $6.52 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $37 Million - $45.9 Million
-809,178 Reduced 18.82%
3,490,606 $181 Million
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $21.1 Million - $31.3 Million
-510,935 Reduced 10.62%
4,299,784 $254 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $273,062 - $350,771
6,957 Added 0.14%
4,810,719 $207 Million
Q2 2021

Aug 16, 2021

BUY
$35.91 - $40.68 $155 Million - $175 Million
4,307,185 Added 867.38%
4,803,762 $188 Million
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $80.8 Million - $91.1 Million
-2,411,489 Reduced 82.92%
496,577 $18 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $53.1 Million - $67.6 Million
1,587,972 Added 120.29%
2,908,066 $107 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $54 Million - $63.3 Million
-1,699,522 Reduced 56.28%
1,320,094 $48.4 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $6.84 Million - $8.3 Million
-227,020 Reduced 6.99%
3,019,616 $98.7 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $44.9 Million - $64.1 Million
-1,660,092 Reduced 33.83%
3,246,636 $106 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $12.4 Million - $14.1 Million
378,034 Added 8.35%
4,906,728 $192 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $78.1 Million - $101 Million
2,403,579 Added 113.1%
4,528,694 $163 Million
Q2 2019

Aug 15, 2019

BUY
$36.98 - $41.52 $29.6 Million - $33.2 Million
800,186 Added 60.39%
2,125,115 $92.1 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $116 Million - $130 Million
-3,134,287 Reduced 70.29%
1,324,929 $29.4 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $125 Million - $137 Million
3,323,196 Added 292.53%
4,459,216 $189 Million
Q4 2018

Feb 14, 2019

BUY
$38.47 - $43.86 $37.3 Million - $42.5 Million
968,287 Added 577.28%
1,136,020 $49.6 Million
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $8.91 Million - $10.8 Million
-258,614 Reduced 60.66%
167,733 $7.39 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $45.4 Million - $48.4 Million
-1,377,676 Reduced 76.37%
426,347 $15.5 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $55.1 Million - $64 Million
-1,727,643 Reduced 48.92%
1,804,023 $64 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $35.7 Million - $37.9 Million
1,074,372 Added 43.72%
3,531,666 $128 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $76.2 Million - $83.9 Million
2,457,294
2,457,294 $87.7 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.